CN100372511C - 一种脱细胞真皮基质 - Google Patents
一种脱细胞真皮基质 Download PDFInfo
- Publication number
- CN100372511C CN100372511C CNB2005101261086A CN200510126108A CN100372511C CN 100372511 C CN100372511 C CN 100372511C CN B2005101261086 A CNB2005101261086 A CN B2005101261086A CN 200510126108 A CN200510126108 A CN 200510126108A CN 100372511 C CN100372511 C CN 100372511C
- Authority
- CN
- China
- Prior art keywords
- skin
- acellular dermal
- dermal matrix
- tissue
- sodium hydroxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000002500 effect on skin Effects 0.000 title claims abstract description 102
- 239000011159 matrix material Substances 0.000 title claims abstract description 95
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 60
- 239000003599 detergent Substances 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 241000124008 Mammalia Species 0.000 claims abstract description 7
- 238000007920 subcutaneous administration Methods 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims description 16
- 241000283690 Bos taurus Species 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 238000012545 processing Methods 0.000 claims description 8
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 7
- 229920000053 polysorbate 80 Polymers 0.000 claims description 7
- 241001494479 Pecora Species 0.000 claims description 5
- 238000006073 displacement reaction Methods 0.000 claims description 5
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 4
- 239000002510 pyrogen Substances 0.000 claims description 4
- 241000282898 Sus scrofa Species 0.000 claims description 3
- 241000283073 Equus caballus Species 0.000 claims description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 2
- 206010067868 Skin mass Diseases 0.000 claims description 2
- 238000012958 reprocessing Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 28
- 238000004140 cleaning Methods 0.000 abstract 2
- 239000004615 ingredient Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 73
- 206010052428 Wound Diseases 0.000 description 64
- 208000027418 Wounds and injury Diseases 0.000 description 64
- 210000001519 tissue Anatomy 0.000 description 57
- 230000002980 postoperative effect Effects 0.000 description 46
- 210000002950 fibroblast Anatomy 0.000 description 35
- 210000004027 cell Anatomy 0.000 description 25
- 239000013641 positive control Substances 0.000 description 23
- 108010035532 Collagen Proteins 0.000 description 21
- 102000008186 Collagen Human genes 0.000 description 21
- 229920001436 collagen Polymers 0.000 description 21
- 241001465754 Metazoa Species 0.000 description 17
- 239000000463 material Substances 0.000 description 14
- 230000029663 wound healing Effects 0.000 description 13
- 239000012620 biological material Substances 0.000 description 11
- 230000008439 repair process Effects 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 230000007547 defect Effects 0.000 description 10
- 238000011160 research Methods 0.000 description 10
- 208000018756 Variant Creutzfeldt-Jakob disease Diseases 0.000 description 9
- 208000005881 bovine spongiform encephalopathy Diseases 0.000 description 9
- 238000009954 braiding Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 230000035876 healing Effects 0.000 description 7
- 210000004872 soft tissue Anatomy 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 206010020718 hyperplasia Diseases 0.000 description 6
- 210000004969 inflammatory cell Anatomy 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000008595 infiltration Effects 0.000 description 5
- 238000001764 infiltration Methods 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 231100000241 scar Toxicity 0.000 description 5
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 4
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 4
- 210000002744 extracellular matrix Anatomy 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 230000037311 normal skin Effects 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010063560 Excessive granulation tissue Diseases 0.000 description 3
- 208000028990 Skin injury Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 210000000589 cicatrix Anatomy 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 210000001126 granulation tissue Anatomy 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 230000005847 immunogenicity Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 210000002200 mouth mucosa Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000007493 shaping process Methods 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 206010048282 zoonosis Diseases 0.000 description 3
- 108010023728 Alloderm Proteins 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 241000381142 Pachydermia Species 0.000 description 2
- 230000000735 allogeneic effect Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000009390 chemical decontamination Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000834 fixative Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 210000001847 jaw Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 210000004003 subcutaneous fat Anatomy 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010062049 Lymphocytic infiltration Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 241001482564 Nyctereutes procyonoides Species 0.000 description 1
- 241000283870 Oryx gazella Species 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 206010067268 Post procedural infection Diseases 0.000 description 1
- 235000016979 Quercus ilex Nutrition 0.000 description 1
- 240000004127 Quercus ilex Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 241000272534 Struthio camelus Species 0.000 description 1
- 206010060872 Transplant failure Diseases 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- CJDPJFRMHVXWPT-UHFFFAOYSA-N barium sulfide Chemical compound [S-2].[Ba+2] CJDPJFRMHVXWPT-UHFFFAOYSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000000280 densification Methods 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000003328 fibroblastic effect Effects 0.000 description 1
- 210000000630 fibrocyte Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 210000001983 hard palate Anatomy 0.000 description 1
- 201000000615 hard palate cancer Diseases 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000009851 immunogenic response Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
术后2周 | 术后3周 | 术后4周 | 术后6周 | 术后12周 | |
正常组 | 4.36±0.00215 | 2.27±0.00062 | 2.84±0.0004 | 2.68±0.00087 | 6.12±0.00184 |
单纯创伤组 | 1.83±0.00125<sup>△</sup> | 6.96±0.01266<sup>△</sup> | 5.59±0.00064<sup>△</sup> | 16.49±0.03039<sup>△</sup> | 15.74±0.03008<sup>△</sup> |
阳性对照组 | 3.10±0.00139 | 1.90±0.00004 | 2.90±0.00125 | 5.52±0.01625 | 5.35±0.00065 |
实验组 | 2.54±0.00066 | 2.98±0.0002<sup>▲</sup> | 5.66±0.00058<sup>▲</sup> | 4.56±0.0013 | 5.72±0.00169 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101261086A CN100372511C (zh) | 2005-11-30 | 2005-11-30 | 一种脱细胞真皮基质 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101261086A CN100372511C (zh) | 2005-11-30 | 2005-11-30 | 一种脱细胞真皮基质 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1775189A CN1775189A (zh) | 2006-05-24 |
CN100372511C true CN100372511C (zh) | 2008-03-05 |
Family
ID=36764991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005101261086A Active CN100372511C (zh) | 2005-11-30 | 2005-11-30 | 一种脱细胞真皮基质 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100372511C (zh) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101274106B (zh) * | 2008-03-24 | 2011-11-09 | 中山大学中山眼科中心 | 一种制备脱细胞基质的方法 |
CN102462561A (zh) * | 2010-11-19 | 2012-05-23 | 北京迈迪顶峰医疗科技有限公司 | 一种sis软组织修复补片及其制备方法 |
CN102178981B (zh) * | 2011-04-20 | 2013-08-28 | 北京市创伤骨科研究所 | 一种软骨修复支架材料的制备方法 |
CN103083726A (zh) * | 2013-03-04 | 2013-05-08 | 昆明市第一人民医院 | 一种肝脏组织脱细胞液 |
EP3928806A1 (en) * | 2013-03-15 | 2021-12-29 | University of Florida Research Foundation, Inc. | Method for decellularization of tissue grafts |
CN103272271B (zh) * | 2013-05-22 | 2014-11-05 | 烟台正海生物技术有限公司 | 用于治疗疝气的外科补片及其制备方法 |
CN103239760B (zh) * | 2013-05-22 | 2014-11-05 | 烟台正海生物技术有限公司 | 防粘连外科补片及其制备方法 |
CN104174068B (zh) * | 2013-05-22 | 2016-02-17 | 烟台正海生物科技股份有限公司 | 一种生物型软骨修复材料及其制备方法 |
CN103272272B (zh) * | 2013-05-22 | 2014-11-19 | 烟台正海生物技术有限公司 | 一种天然具孔皮肤补片及其制备方法 |
CN104174069B (zh) * | 2013-05-22 | 2016-06-29 | 烟台正海生物科技股份有限公司 | 一种致密骨基质及其制备方法 |
CN103272270B (zh) * | 2013-05-22 | 2014-11-19 | 烟台正海生物技术有限公司 | 一种管状外科补片及其制备方法 |
CN104174066B (zh) * | 2013-05-22 | 2016-02-17 | 烟台正海生物科技股份有限公司 | 一种天然生物骨材料及其制备方法 |
CN104857564A (zh) * | 2015-04-27 | 2015-08-26 | 中国科学院遗传与发育生物学研究所 | 一种引导尿道再生的功能性生物支架材料及其制备方法 |
CN106256381A (zh) * | 2015-06-18 | 2016-12-28 | 北京朗嘉仪生物技术有限公司 | 有序修复材料及其制备方法和用途 |
CN106256382A (zh) * | 2015-06-18 | 2016-12-28 | 北京朗嘉仪生物技术有限公司 | 膀胱膜生物支架及其制备方法和用途 |
CN106139250A (zh) * | 2016-07-29 | 2016-11-23 | 烟台正海生物科技股份有限公司 | 一种脱细胞异种神经移植物及其制备方法 |
CN106880871B (zh) * | 2017-01-18 | 2019-12-13 | 烟台正海生物科技股份有限公司 | 一种用于促进子宫内膜修复的胶原蛋白真皮材料及其制备方法 |
CN109821071B (zh) * | 2019-02-22 | 2021-08-17 | 上海仁康科技有限公司 | 一种基于脱细胞真皮基质的水凝胶及其制备方法 |
WO2022173066A1 (ko) * | 2021-02-15 | 2022-08-18 | 주식회사 엘앤씨바이오 | 유방재건용 무세포화 피부대체재 및 그 제조방법 |
CN113180897A (zh) * | 2021-03-17 | 2021-07-30 | 南微医学科技股份有限公司 | 一种植皮支架及置入系统 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1387923A (zh) * | 2002-07-11 | 2003-01-01 | 中国人民解放军第二军医大学 | 异种无细胞真皮支架及其制备方法 |
CN1460527A (zh) * | 2003-07-03 | 2003-12-10 | 中国人民解放军第三○四医院 | 选择性去细胞猪皮作为人体皮肤代替物的应用及其制备方法 |
US20040024447A1 (en) * | 2000-04-27 | 2004-02-05 | Axel Haverich | Individual venous valve prosthesis |
US20040052830A1 (en) * | 2000-12-20 | 2004-03-18 | Wolfgang Konertz | Method for decellularising foreign material for the production of bioprostheses |
JP2004107303A (ja) * | 2002-09-20 | 2004-04-08 | Yoshihiro Takami | 皮膚の無細胞化方法、該方法による無細胞化真皮マトリックス及びその製造方法並びに該マトリックスを用いた複合培養皮膚 |
CN1522766A (zh) * | 2003-09-05 | 2004-08-25 | 东南大学 | 脱细胞真皮基质的制备方法 |
CN1569260A (zh) * | 2004-05-12 | 2005-01-26 | 四川大学 | 脱细胞真皮基质材料的制备方法 |
CN1587390A (zh) * | 2004-07-22 | 2005-03-02 | 中国人民解放军三○四医院 | 无细胞毒性猪去细胞真皮基质的制备及应用 |
JP2005185507A (ja) * | 2003-12-25 | 2005-07-14 | Yoshihiro Takami | 皮膚の分離無細胞化方法、無細胞化真皮マトリックス及びその製造方法並びに無細胞化真皮マトリックスを用いた複合培養皮膚 |
US20050186286A1 (en) * | 2004-02-25 | 2005-08-25 | Yoshihiro Takami | Skin decellularization method, acellular dermal matrix and production method therefore employing said decellularization method, and composite cultured skin employing said matrix |
-
2005
- 2005-11-30 CN CNB2005101261086A patent/CN100372511C/zh active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040024447A1 (en) * | 2000-04-27 | 2004-02-05 | Axel Haverich | Individual venous valve prosthesis |
US20040052830A1 (en) * | 2000-12-20 | 2004-03-18 | Wolfgang Konertz | Method for decellularising foreign material for the production of bioprostheses |
CN1387923A (zh) * | 2002-07-11 | 2003-01-01 | 中国人民解放军第二军医大学 | 异种无细胞真皮支架及其制备方法 |
JP2004107303A (ja) * | 2002-09-20 | 2004-04-08 | Yoshihiro Takami | 皮膚の無細胞化方法、該方法による無細胞化真皮マトリックス及びその製造方法並びに該マトリックスを用いた複合培養皮膚 |
CN1460527A (zh) * | 2003-07-03 | 2003-12-10 | 中国人民解放军第三○四医院 | 选择性去细胞猪皮作为人体皮肤代替物的应用及其制备方法 |
CN1522766A (zh) * | 2003-09-05 | 2004-08-25 | 东南大学 | 脱细胞真皮基质的制备方法 |
JP2005185507A (ja) * | 2003-12-25 | 2005-07-14 | Yoshihiro Takami | 皮膚の分離無細胞化方法、無細胞化真皮マトリックス及びその製造方法並びに無細胞化真皮マトリックスを用いた複合培養皮膚 |
US20050186286A1 (en) * | 2004-02-25 | 2005-08-25 | Yoshihiro Takami | Skin decellularization method, acellular dermal matrix and production method therefore employing said decellularization method, and composite cultured skin employing said matrix |
CN1569260A (zh) * | 2004-05-12 | 2005-01-26 | 四川大学 | 脱细胞真皮基质材料的制备方法 |
CN1587390A (zh) * | 2004-07-22 | 2005-03-02 | 中国人民解放军三○四医院 | 无细胞毒性猪去细胞真皮基质的制备及应用 |
Non-Patent Citations (1)
Title |
---|
NaOH消蚀法制备胎儿脱细胞真皮基质的研究. 夏建春,米立国,高英,王丽.中国临床解剖学杂志,第23卷第4期. 2005 * |
Also Published As
Publication number | Publication date |
---|---|
CN1775189A (zh) | 2006-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100372511C (zh) | 一种脱细胞真皮基质 | |
Llames et al. | Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin | |
CN106860919B (zh) | 交联脱细胞羊膜及其制备方法和应用 | |
Wang et al. | Regenerative porcine dermal collagen matrix developed by supercritical carbon dioxide extraction technology: Role in accelerated wound healing | |
Kremer et al. | Evaluation of dermal—epidermal skin equivalents (‘composite-skin’) of human keratinocytes in a collagen-glycosaminoglycan matrix (integra™ artificial skin) | |
CN101954124B (zh) | 含基底膜的组织工程皮肤的构建方法 | |
JPS58501772A (ja) | 遠心による繊維格子中への細胞の接種方法 | |
CN102631706B (zh) | 低免疫原性猪真皮支架的制备方法 | |
CN1185019C (zh) | 应用中和脱乙酰壳多糖海绵或中和脱乙酰壳多糖/胶原混合海绵的皮肤支架 | |
Shukla et al. | Acellular dermis as a dermal matrix of tissue engineered skin substitute for burns treatment | |
Kangesu et al. | A porcine model using skin graft chambers for studies on cultured keratinocytes | |
CN108057116A (zh) | 干细胞组合物在皮肤损伤治疗药物中的应用 | |
CN114939128A (zh) | 骨髓间充质干细胞外泌体在修复关节软骨缺损中的应用 | |
CN107233623A (zh) | 一种可用于组织工程皮肤生物支架的脱细胞羊膜的制备方法 | |
CN107890586B (zh) | 一种同种异体生物乳房补片的制备方法 | |
CN105018417B (zh) | 负载羊膜固有干细胞的冻存活性羊膜微粒及其条件培养基与应用 | |
EP1137449A1 (en) | Skin composites | |
CN108066750A (zh) | 干细胞及其分泌物用于治疗皮肤烧烫伤的新用途 | |
WO2014117597A2 (zh) | 快速组织工程皮肤构建修复皮肤缺损的方法 | |
Xia et al. | Preparation of laser microporous porcine acellular dermal matrix and observation of wound transplantation | |
Mohsina et al. | Bioengineered acellular dermal matrices for the repair of abdominal wall defects in rats | |
CN1234429C (zh) | 一种人工皮肤及其制备方法与应用 | |
CN100496623C (zh) | 异种脱蛋白骨支架材料及其制备方法 | |
CN108057131A (zh) | 一种含有干细胞的新型试剂盒 | |
Huh et al. | Rapid expansion and auto-grafting efficiency of porcine full skin expanded by a skin bioreactor ex vivo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: YANTAI ZHENGHAI BIO-TECH CO., LTD. Free format text: FORMER NAME: ZHENGHAI BIOLOGICAL TECHNOLOGY CO., LTD., YANTAI |
|
CP01 | Change in the name or title of a patent holder |
Address after: 264006 No. 10, Yantai economic and Technological Development Zone, Shandong, Hengshan Road Patentee after: YANTAI ZHENGHAI BIO-TECH CO., LTD. Address before: 264006 No. 10, Yantai economic and Technological Development Zone, Shandong, Hengshan Road Patentee before: Zhenghai Biological Technology Co., Ltd., Yantai |
|
CP02 | Change in the address of a patent holder |
Address after: 264006 No.7 Nanjing Street, Yantai Economic and Technological Development Zone, Yantai City, Shandong Province Patentee after: YANTAI ZHENGHAI BIO-TECH Co.,Ltd. Address before: 264006 No. 10, Yantai economic and Technological Development Zone, Shandong, Hengshan Road Patentee before: YANTAI ZHENGHAI BIO-TECH Co.,Ltd. |
|
CP02 | Change in the address of a patent holder |